|
SOCS5 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.45929999884854E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.66140000001924E-06 |
| Normal-vs-Stage2 |
3.095300E-03 |
| Normal-vs-Stage3 |
5.224600E-04 |
| Normal-vs-Stage4 |
2.052000E-01 |
| Stage1-vs-Stage2 |
8.262800E-01 |
| Stage1-vs-Stage3 |
9.138000E-01 |
| Stage1-vs-Stage4 |
6.581800E-01 |
| Stage2-vs-Stage3 |
9.142200E-01 |
| Stage2-vs-Stage4 |
7.159200E-01 |
| Stage3-vs-Stage4 |
6.407200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.21370000003307E-07 |
| Normal-vs-AfricanAmerican |
3.60930000000703E-05 |
| Normal-vs-Asian |
2.49709999999848E-05 |
| Caucasian-vs-AfricanAmerican |
9.765600E-01 |
| Caucasian-vs-Asian |
1.028840E-01 |
| AfricanAmerican-vs-Asian |
3.176400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.77539990989339E-10 |
| Normal-vs-Female |
2.890200E-01 |
| Male-vs-Female |
7.364300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.985300E-04 |
| Normal-vs-Extreme_Weight |
1.69707999999602E-05 |
| Normal-vs-Obese |
1.020110E-02 |
| Normal-vs-Extreme_Obese |
5.9152999999923E-05 |
| Normal_Weight-vs-Extreme_Weight |
9.994600E-01 |
| Normal_Weight-vs-Obese |
1.833850E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.738800E-01 |
| Extreme_Weight-vs-Obese |
1.442030E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.018000E-01 |
| Obese-vs-Extreme_Obese |
2.235400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.662400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.137990E-02 |
| Normal-vs-Age(61-80Yrs) |
1.30940036591198E-10 |
| Normal-vs-Age(81-100Yrs) |
2.12349999999528E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.607000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.983150E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.087400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.024200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.470000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.413800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.11329999961252E-07 |
| Normal-VS-Type2 PRCC |
6.46550035732218E-10 |
| Normal-VS-KIRP CIMP |
4.816200E-01 |
| Normal-VS-Unclassified PRCC |
1.147550E-01 |
| Type1 PRCC-VS-Type2 PRCC |
7.096100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.935200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.060600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.710400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.670100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.839200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.83661982791727E-12 |
| Normal-vs-N1 |
4.676500E-02 |
| Normal-vs-N2 |
7.336800E-01 |
| N0-vs-N1 |
1.610040E-02 |
| N0-vs-N2 |
1.561650E-02 |
| N1-vs-N2 |
6.352000E-01 |
|
|
